AUA 2006 - The Age-Related Decline in Testosterone is Significantly Exacerbated in Obese Men with the Metabolic Syndrome: What are the Implications of this for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?
Monday, 22 May 2006
Abstract 692
At the recent annual meeting of the American Urological Association, Dr. Steven Kaplan of New York added to the accumulating evidence that serum testosterone (T) is associated with the Metabolic Syndrome (METS).
read more
|
AUA 2006 - Effects of Testosterone Administration on Prostate Tissues in Men with ADAM Syndrome
Monday, 22 May 2006
Abstract 691
Dr. Leonard Marks, Culver City, California reported a multicenter randomized clinical trial of the effects of testosterone (T) administration on prostate tissues in 48 patients with androgen decline of aging male (ADAM).
read more
|
AUA 2006 - Correction of Penile Deformity: Long-term Outcomes of Penile Plication versus Plaque Incision with Venous Graft
Monday, 22 May 2006
Abstract 1003
This was a retrospective comparison study of long-term efficacy and patient satisfaction with corporal plication (N=18) versus incision and venous grafting (N=24) for men with stable Peyronie's disease.
read more
|
AUA 2006 - Circumscribed Septal Fibrosis: Sequelae of Septal Fracture?
Monday, 22 May 2006
Abstract 1000
This was one of two reports during the Peyronie's podium session on isolated septal fibrosis.
read more
|
AUA 2006 - Outcomes and Complications of Porcine Small Intestinal Submucosal Graft in the Surgical Management of Peyronie's Disease
Monday, 22 May 2006
Abstract 999
This was a respective study on a single center experience with a small number of men (N = 99) undergoing penile reconstruction for PD with plaque incision/partial excision and 1-layer porcine SIS grafting.
read more
|
AUA 2006 - Demographics and Mental Health Status of Men with Peyronie's Disease: An Association of Peyronie's Disease Advocates
Monday, 22 May 2006
Abstract 997
This abstract presented an Internet based survey from the association of Peyronie's disease Advocates that examined the demographics and mental health status of men with Peyronie's disease.
read more
|
AUA 2006 - Verapamil versus Saline and Electromotive Drug Administration (EMDA) for Peyronie’s Disease: A Double-Blind Placebo-Control Trial
Monday, 22 May 2006
Abstract 992
This abstract reported on a randomized placebo controlled trial of Verapamil versus Saline delivered by EMDA for Peyronie's disease.
read more
|
AUA 2006 Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of More Than 44,800 Patients in Clinical and Observational Studies
Monday, 22 May 2006
Abstract 697 .
NAION is the acronym for Non-arteritic Anterior Ischemic Optic Neuropathy.
read more
|
AUA 2006 - There is no Significant Difference Between On-Demand PDE5-I vs. PDE5-I as Rehabilitative Treatment in Patients Treated by Bilateral Nerve-Sparing Radical Retropubic Prostatectomy
Monday, 22 May 2006
Abstract 695
Rehabilitative pharmacologic therapy has been promoted as a potentially useful, available approach to facilitate erection recovery following prostate cancer surgery.
read more
|
AUA 2006 - The Effect of Hyperbaric Oxygen Therapy on Erectile Function Recovery in the Rat Cavernous Nerve Injury Model
Monday, 22 May 2006
Abstract 690
Hyperbaric oxygen therapy, conventionally used to promote healing for destructive injury or metabolic disease tissue damage, has been explored to have a role in treating erectile dysfunction.
read more
|
AUA 2006 - Results of the First Human Trial for Gene Transfer Therapy for the Treatment of Erectile Dysfunction
Monday, 22 May 2006
Abstract 686
Gene therapy for erectile dysfunction, the gene transfer of relevant molecules involved in the regulation of penile erection, has emerged from just an imaginable possibility to an exciting reality.
read more
|
AUA 2006 - Session on the History of Urology
Sunday, 04 June 2006
R.M. Engel and R.S. Waldbaum chaired this session. It emphasized aspects of sexuality related to urology.
read more
|
AUA 2006 - Report on AUA Plenary Session
Monday, 22 May 2006
Several interesting presentations highlighted today's plenary session at the annual meeting of the American Urological Association in Atlanta, Georgia.
read more
|
AUA 2006 - Diabetes Mellitus Associated With A Delay In Return Of Continence After Orthotopic Neobladder
Monday, 22 May 2006
Abstract 155
Kessler, Studer et al reviewed their experience with 22 men who underwent cystoprostatectomy and ileal neobladder.
read more
|
AUA 2006 - Novel BioMarker For Aggressive Prostate Cancer
Monday, 22 May 2006
Abstract 237
Obese men exhibit a higher incidence of aggressive prostate cancer histology.
read more
|
AUA 2006 - Robotic Radical Prostatectomy: Positive Margin Rate Decreases With Experience
Monday, 22 May 2006
Abstract 216
Herrell and colleagues from Vanderbilt reviewed that change in incidence of margin positivity as surgeon experience increased with robotic radical prostatectomy.
read more
|
AUA 2006 - Novel Retrovirus Associated With Prostate Cancer Development
Monday, 22 May 2006
Abstract 239
A deficiency in RNAseL, an antiviral protein activated by viral infection, has been linked with prostate carcinogenesis.
read more
|
AUA 2006 - Fine Needle Aspiration Of Inguinal Nodes Predicts Regional Metastasis In Penile Carcinoma
Monday, 22 May 2006
Abstract 460
In patients with penile carcinoma with inguinal adenopathy, patients are traditionally started on oral antibiotics and re-evaluated after therapy to assess resolution.
read more
|
AUA 2006 - Finasteride Improves The Performance Characteristics Of Serum PSA As A Screening Tool: Results From The PCPT
Monday, 22 May 2006
Abstract 470
Thompson and colleagues from the Prostate Cancer Prevention Trial calculated ROC curves for patients in the PCPT to determine the performance characteristics of PSA in men taking finasteride.
read more
|
AUA 2006 - PSA Velocity For Young Men Should Be Lower Than 0.5 NG/ML/YEAR
Monday, 22 May 2006
Abstract 471
Loeb and colleagues reviewed data from 6844 men younger than 60 years who formed part of a prostate cancer screening program. PSA velocity thresholds were evaluated to determine the subsequent risk of developing prostate cancer.
read more
|
AUA 2006 - One Third Of Patients With Residual Masses After Chemotherapy Will Have Disease Outside The Modified Template: The Case For A Bilateral Template Dissection
Monday, 22 May 2006
Abstract 593
Carver et al from Memorial Sloan-Kettering presented data from 532 patients who underwent postchemotherapy RPLND for testis cancer.
read more
|
AUA 2006 - Contemporary Results For Stage I RPLND Less Morbid Than Historical Controls
Monday, 22 May 2006
Abstract 586Beck and colleagues from Indiana performed a review of 73 patients who underwent primary RPLND in the last 2 years to assess short term morbidity.
read more
|
AUA 2006 - Oncological Efficacy Of Laparoscopic RPLND: A Multi-Institutional Review
Monday, 22 May 2006
Abstract 587
Data from 3 institutions were reviewed to assess the recurrence patterns of 143 patients who underwent laparoscopic RPLND for Stage I disease.
read more
|
AUA 2006 - EDG-PET CT Imaging Useful In Penile Cancer Staging
Monday, 22 May 2006
Abstract 601Seitz and colleagues presented data from 17 patients with penile cancer who underwent PET CT imaging.
read more
|
AUA 2006 - Prostate Cancer Watchful Waiting: 100% Cause Specific Survival
Monday, 22 May 2006
Abstract 488
Master and colleagues from USCF presented their data on 240 managed with watchful waiting as initial prostate cancer treatment.
read more
|
AUA 2006 - Smoking Associated With CPG Hypermethylation In Prostate Cancer
Monday, 22 May 2006
Abstract 480
CpG hypermethylation has been associated with advanced prostate cancer.
read more
|
AUA 2006 - Introduction Of Serum PSA Screening Associated With Decreased Prostate Cancer Mortality In Tyrol
Monday, 22 May 2006
Abstract 473
In 1993, PSA and DRE were introduced as part of a free prostate cancer screening program in Tyrol. Eighty percent of patients participated at least once in the program.
read more
|
AUA 2006 - Session 10: Open and Laparoscopic Radical Prostatectomy: Tricks of the Trade Video
Monday, 22 May 2006
By James Borin, MD and Leslie Deane, MDModerator J. Brantley Thrasher MD asked insightful questions of his panel of video authors
read more
|
AUA 2006 - Epidemiological Study Suggests That Alpha-1 Adrenergic Blockers May Decrease Prostate Cancer Risk
Monday, 22 May 2006
Abstract 127 - Wilson and colleagues from Kentucky presented data from 4134 patients identified at the Lexington VA Medical Center as having received alpha-1 adrenergic blocker therapy for BPH or hypertension between 1998 and 2002.
read more
|
AUA 2006 - Androgen Deprivation Therapy Associated With A Significant Risk of De Novo Diabetes Mellitus And Worsening Glycemic Control In Diabetic Patients
Monday, 22 May 2006
Abstract 128While androgen deprivation therapy for prostate cancer is known to result in poor glycemic control, the exact risk of de novo diabetes mellitus has not well defined.
read more
|
AUA 2006 - Agent Orange Exposure May Be Associated With An Increased Risk Of Biochemical Progression In Prostate Cancer
Monday, 22 May 2006
Abstract 131
Of 869 patients who underwent radical prostatectomy at 3 VA Medical Centers, a history of Agent Orange exposure was identified in 10% of patients.
read more
|
AUA 2006 - Men In Their 40s With An Increased Risk Of Prostate Cancer: What Is Their Risk Of Developing Prostate Cancer If Their Initial PSA Is Below The Median (0.7 NG/ML)?
Monday, 22 May 2006
African American patients or those with a positive family history are at a significantly increased risk of prostate cancer.
read more
|
Conference Coverage 
